Information Journal Paper
APA:
CopyEBRAHIMI, ELMIRA, & SHIRKOOHI, REZA. (2018). What Is the Best Risk-Reducing Decision for Breast Cancer Patients With BRCA1/2 Mutation? (Invited Commentary). ARCHIVES OF BREAST CANCER, 5(4), 148-149. SID. https://sid.ir/paper/349110/en
Vancouver:
CopyEBRAHIMI ELMIRA, SHIRKOOHI REZA. What Is the Best Risk-Reducing Decision for Breast Cancer Patients With BRCA1/2 Mutation? (Invited Commentary). ARCHIVES OF BREAST CANCER[Internet]. 2018;5(4):148-149. Available from: https://sid.ir/paper/349110/en
IEEE:
CopyELMIRA EBRAHIMI, and REZA SHIRKOOHI, “What Is the Best Risk-Reducing Decision for Breast Cancer Patients With BRCA1/2 Mutation? (Invited Commentary),” ARCHIVES OF BREAST CANCER, vol. 5, no. 4, pp. 148–149, 2018, [Online]. Available: https://sid.ir/paper/349110/en